Product Information

METRONIDAZOLE 250 MG TABLET is a generic product labeled by AvPAK, priced at $0.1237 per EA under NDC 50268053415. Its NADAC has been published 343 times since Apr 29, 2020.

FDA first approved this application on Mar 13, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METRONIDAZOLE 250 MG TABLET

Metronidazole
$0.1237per EA

Strength

250 mg/1

Manufacturer

AvPAK

NDC

50268053415

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

METRONIDAZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA079067

FDA Approved

3/13/2009

TE Code

AB

On Market Since

10/30/2019

Pharmacological Classes

Price Statistics

The NADAC for METRONIDAZOLE 250 MG TABLET has been published 343 times since Apr 29, 2020, and over the history we have for it it has declined 17.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1237 per EA
All-time high$0.1506 (May 13, 2020)
All-time low$0.0623 (Dec 17, 2025)
52-week high$0.1237
52-week low$0.0623
Median price$0.1100
Average price$0.1095
Largest weekly change-35.7% (Feb 21, 2024)
Weeks tracked343
Tracking sinceApr 29, 2020

Price History

1W

+14.7%

1M

+21.7%

3M

+15.8%

6M

+47.6%

1Y

+70.8%

3Y

+10.0%

5Y

+6.1%

All

-17.8%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 22% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METRONIDAZOLE 250 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE 250 MG TABLET, manufactured by AvPAK, is $0.1237 per EA (NDC 50268053415), effective Nov 18, 2026.

How has the price of METRONIDAZOLE 250 MG TABLET changed over time?

Over the history we have for it, the NADAC for METRONIDAZOLE 250 MG TABLET has declined 17.8%. It has been tracked across 343 weekly CMS publications since Apr 29, 2020.

What are the highest and lowest recorded NADAC prices for METRONIDAZOLE 250 MG TABLET?

Since Apr 29, 2020, the NADAC for METRONIDAZOLE 250 MG TABLET has ranged from a low of $0.0623 (Dec 17, 2025) to a high of $0.1506 (May 13, 2020), with a median of $0.1100 per EA.

Are there cheaper alternatives to METRONIDAZOLE 250 MG TABLET?

Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METRONIDAZOLE 250 MG TABLET, is $0.0970 per EA — about 22% below METRONIDAZOLE 250 MG TABLET.

Who manufactures METRONIDAZOLE 250 MG TABLET?

METRONIDAZOLE 250 MG TABLET (NDC 50268053415) is labeled by AvPAK, and CMS classifies it as a generic product.